MAZE
Maze Therapeutics, Inc.
26.40$
-0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 87.9% | -928.2% | – | – | – | – | – | -195.6% | – | -532.7% | |
| – | – | – | 0.5% | 31.5% | – | – | – | – | – | 2.2% | – | 9.5% | |
| – | – | – | 1.3% | 93.7% | – | – | – | – | – | 35.5% | – | 131.2% | |
| – | – | – | 1.5% | -209.3% | – | – | – | – | – | -118.4% | – | -101.0% | |
| – | – | – | 0.1% | 4.1% | – | – | – | – | – | 0.5% | – | 1.5% | |
| – | – | – | -0.1% | -4.1% | – | – | – | – | – | 31.4% | – | -1,462.5% | |
| – | – | – | – | 0.0% | – | – | – | – | – | 197.0% | – | 197.0% | |
| – | – | – | 0.1% | -86.0% | – | – | – | – | – | 211.8% | – | 1,685.7% | |
| – | – | – | 87.9% | -1,018.3% | – | – | – | – | – | 47.6% | – | -309.5% | |
| – | – | – | 87.8% | -932.3% | – | – | – | – | – | -196.0% | – | -534.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.